76350719
Dec 19, 2001
Oct 22, 2002
Pharmaceutical drug development services, namely, custom manufacture of oxygen radical scavengers such as superoxide dismutase mimetics and metal binding ligands such as [polyhydroxamtes] * polyhydroxamates *
Treatment of MaterialsPharmaceutical drug development services, namely, the design of oxygen radical scavengers such as superoxide dismutase mimetics and metal binding ligands such as polyhydroxamates
Computer and Scientific